chronic bronchitis treatment options

The Lung Institute Offers Alternative Chronic Bronchitis Treatment Options

Viable alternative treatment options for chronic bronchitis include cellular therapy procedures available at the Lung Institute. As the only cellular therapy clinic in the world that focuses solely on the treatment of lung conditions, we have an exceptional understanding of pulmonary care and the many facets of treating various forms of lung disease, including chronic bronchitis. Unlike many traditional forms of treatment like oxygen therapy and medication that work to simply mitigate symptoms, cellular therapy has been shown to potentially slow the progression of lung disease and improve the patient’s quality of life in certain cases. While cellular therapy cannot reverse or cure lung disease, it can possibly reduce lung inflammation and improve lung function.

The Lung Institute offers cellular therapy:

  • Blood-Derived Therapy – This form of cellular therapy involves drawing blood from the patient’s own body, separating the cells from the other cells in our onsite lab and then immediately reintroducing the separated cells into the patient’s body intravenously.

Each patient’s ideal course of treatment depends on his or her individual diagnosis and medical history, among many other factors. A dedicated Lung Institute team member works with each patient to determine which form of cellular therapy is ideal for his or her specific situation. Both procedures are performed in one of our bright and modern outpatient facilities over the course of two days, and most patients are able to return to their daily activities immediately following the procedure.

To learn more about the cellular therapy procedures we offer as alternative treatment options for chronic bronchitis, call the Lung Institute today at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.